Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 3;9(2):e14200.
doi: 10.2196/14200.

Nurse-Delivered Cognitive Behavioral Therapy for Adherence and Depression Among People Living With HIV (the Ziphamandla Study): Protocol for a Randomized Controlled Trial

John A Joska  1 , Lena S Andersen  1 , Rosana Smith-Alvarez  2 , Jessica Magidson  3 , Jasper S Lee  2 , Conall O'Cleirigh  4 , Steven A Safren  2
Affiliations

Nurse-Delivered Cognitive Behavioral Therapy for Adherence and Depression Among People Living With HIV (the Ziphamandla Study): Protocol for a Randomized Controlled Trial

John A Joska et al. JMIR Res Protoc. .

Erratum in

Abstract

Background: There is an unmet need to develop effective, feasible, and scalable interventions for poor adherence and depression in persons living with HIV in low- and middle-income countries (LMIC).

Objective: This study aims to investigate the effectiveness of a nurse-delivered cognitive behavioral therapy (CBT) intervention for adherence and depression (CBT-AD) among persons living with HIV who are failing first-line antiretroviral therapy (ART) in Cape Town, South Africa.

Methods: This study is a 2-arm randomized controlled trial of CBT-AD integrated into the HIV primary care setting in South Africa. A total of 160 participants who did not achieve viral suppression from their first-line ART and have a unipolar depressive mood disorder will be randomized to receive either 8 sessions of CBT-AD or enhanced treatment as usual. Participants will be assessed for major depressive disorder using the Mini International Neuropsychiatric Interview at baseline and 4, 8, and 12 months. The primary outcomes are depression on the Hamilton Depression Scale (HAM-D; as assessed by a blinded assessor) at the 4-month assessment and changes in ART adherence (assessed via real-time, electronic monitoring with Wisepill) between baseline and the 4-month assessment. Secondary outcomes are HIV viral load and CD4 cell count at the 12-month assessment as well as ART adherence (Wisepill) and depression (HAM-D) over follow-up (4-, 8-, and 12-month assessments).

Results: The trial commenced in August 2015 and recruitment began in July 2016. Enrollment was completed in June 2019.

Conclusions: Results of this study will inform whether an existing intervention (CBT-AD) can be effectively administered in LMIC by nurses with training and ongoing supervision. This will present unique opportunities to further explore the scale-up of a behavioral intervention to enhance ART adherence among persons living with HIV with major depression in a high-prevalence setting, to move toward achieving The Joint United Nations Programme on HIV/AIDS 90-90-90 goals.

Trial registration: ClincialTrials.gov NCT02696824; https://clinicaltrials.gov/ct2/show/NCT02696824.

International registered report identifier (irrid): DERR1-10.2196/14200.

Keywords: HIV; cognitive behavioral therapy; integrated treatment; major depressive disorder; medication adherence; task shifting.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: SAS receives royalties from Oxford University Press on CBT manuals addressing adherence and depression in chronic illness. He also receives royalties from Oxford University Press, Guilford Publications, and Springer/Humana Press for books that address the delivery of CBT and related issues. The other authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Consolidated standards of reporting trials diagram. CBT-AD: cognitive behavioral therapy for adherence and depression; ETAU: enhanced treatment as usual; SOC: standard of care; 4M: 4-month; 8M: 8-month; 12M: 12-month.
See this image and copyright information in PMC

References

    1. Shisana O, Rehle T, Simbayi L, Zuma K, Jooste S, Zungu N, Labadarios D, Onoya D. Human Sciences Research Council Press. 2014. [2019-03-07]. South African National HIV Prevalence, Incidence and Behaviour Survey, 2012 Internet http://hdl.handle.net/20.500.11910/2490.
    1. Abdool Karim SS, Churchyard GJ, Karim QA, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009 Sep 12;374(9693):921–33. doi: 10.1016/S0140-6736(09)60916-8. http://europepmc.org/abstract/MED/19709731 - DOI - PMC - PubMed
    1. Takuva S, Brown AE, Pillay Y, Delpech V, Puren AJ. The continuum of HIV care in South Africa: implications for achieving the second and third UNAIDS 90-90-90 targets. AIDS. 2017 Feb 20;31(4):545–552. doi: 10.1097/QAD.0000000000001340. - DOI - PubMed
    1. Peltzer K, Szrek H, Ramlagan S, Leite R, Chao L. Depression and social functioning among HIV-infected and uninfected persons in South Africa. AIDS Care. 2015;27(1):41–6. doi: 10.1080/09540121.2014.946383. http://europepmc.org/abstract/MED/25105215 - DOI - PMC - PubMed
    1. Freeman M, Nkomo N, Kafaar Z, Kelly K. Factors associated with prevalence of mental disorder in people living with HIV/AIDS in South Africa. AIDS Care. 2007 Nov;19(10):1201–9. doi: 10.1080/09540120701426482. - DOI - PubMed

Associated data